# Botulinum Toxin to Improve Results in Epicanthoplasty

> **NCT03294382** · PHASE3 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 42 (estimated)

## Conditions studied

- Scar
- Intercanthal Distance Ratio

## Interventions

- **DRUG:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03294382
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-04-01
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2017-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03294382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03294382, "Botulinum Toxin to Improve Results in Epicanthoplasty". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03294382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*